Molecular Pharmacology (USA) MLPH Stock
Molecular Pharmacology (USA) Price Chart
Molecular Pharmacology (USA) MLPH Financial and Trading Overview
| Molecular Pharmacology (USA) stock price | 0.0015 USD |
| Previous Close | 0.0003 USD |
| Open | 0.0003 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0003 - 0.0003 USD |
| 52 Week Range | 0.0001 - 0.005 USD |
| Volume | 10K USD |
| Avg. Volume | 2.07K USD |
| Market Cap | 214.18K USD |
| Beta (5Y Monthly) | 44.69507 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MLPH Valuation Measures
| Enterprise Value | 2.11M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -21.484 |
Trading Information
Molecular Pharmacology (USA) Stock Price History
| Beta (5Y Monthly) | 44.69507 |
| 52-Week Change | 200.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.005 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.000174 USD |
| 200-Day Moving Average | 0.0002995 USD |
MLPH Share Statistics
| Avg. Volume (3 month) | 2.07K USD |
| Avg. Daily Volume (10-Days) | 6.18K USD |
| Shares Outstanding | 111.55M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2014 |
| Most Recent Quarter (mrq) | September 30, 2014 |
| Next Fiscal Year End | June 30, 2015 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -569.41% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -98105 USD |
| Net Income Avi to Common (ttm) | -105181 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.52K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 2.08M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.276 |
| Book Value Per Share (mrq) | -0.019 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -109348 USD |
| Levered Free Cash Flow (ttm) | -65607 USD |
Profile of Molecular Pharmacology (USA)
| Country | United States |
| State | WA |
| City | Perth |
| Address | Drug Discovery Centre |
| ZIP | 6007 |
| Phone | 61 8 9443 3011 |
| Website | N/A |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Molecular Pharmacology (USA) Limited, a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States. The company, through its subsidiary, Molecular Pharmacology Pty. Ltd., develops analgesic and anti-inflammatory molecule, known as Tripeptofen for the treatment of common every-day pain. Its products are available in various dosage forms, formulations, line extensions, and package configurations. The company focuses on marketing its products through pharmaceutical distributors, and through collaborative dealings with companies in the United States and Europe. It also has an agreement with Dermatology Development Corporation to develop and market a range of therapeutic, cosmetic, and cosmecutical products based on the ThermaLIFE product range and its active ingredient. The company is based in Perth, Australia. Molecular Pharmacology (USA) Limited is a subsidiary of PharmaNet Group Limited.
Q&A For Molecular Pharmacology (USA) Stock
What is a current MLPH stock price?
Molecular Pharmacology (USA) MLPH stock price today per share is 0.0015 USD.
How to purchase Molecular Pharmacology (USA) stock?
You can buy MLPH shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Molecular Pharmacology (USA)?
The stock symbol or ticker of Molecular Pharmacology (USA) is MLPH.
Which industry does the Molecular Pharmacology (USA) company belong to?
The Molecular Pharmacology (USA) industry is Biotechnology.
How many shares does Molecular Pharmacology (USA) have in circulation?
The max supply of Molecular Pharmacology (USA) shares is 142.79M.
What is Molecular Pharmacology (USA) Price to Earnings Ratio (PE Ratio)?
Molecular Pharmacology (USA) PE Ratio is now.
What was Molecular Pharmacology (USA) earnings per share over the trailing 12 months (TTM)?
Molecular Pharmacology (USA) EPS is 0 USD over the trailing 12 months.
Which sector does the Molecular Pharmacology (USA) company belong to?
The Molecular Pharmacology (USA) sector is Healthcare.